Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

CLRB

Cellectar Biosciences, Inc.

CIK 0001279704 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$2.77
↑ 0.08 (2.97%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$22.14M
P/E Ratio
-1.06
EPS
-8.35
Dividend Yield
Not covered
52W Position
13%
Beta
1.94

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
6.64
P/S
Not covered
EV/Revenue
Not covered
ROE
-624.9%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 13%
$2.20$6.52

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$21.79M
Total Assets
$14.98M
Free Cash Flow
-$23.12M

Recent news